drugset / Trial / NCT00021359

Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma

NCT00021359

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with dexamethasone may be an effective treatment for multiple myeloma. PURPOSE: Phase II trial to study the effectiveness of combining isotretinoin and dexamethasone in treating patients who have multiple myeloma.

Timeline

Start
1999-08
Primary completion
2000-07
Completion
2005-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule Oral
Subject Isotretinoin Other / unclassified Oral

Indications